欢迎来到《四川大学学报(医学版)》 2025年6月10日 星期二

二甲双胍联合MCT1抑制剂α-氰基-4-羟基苯乙烯治疗小鼠Lewis肺癌的研究

郭福春, 王力强, 张静, 王永生

郭福春, 王力强, 张静, 等. 二甲双胍联合MCT1抑制剂α-氰基-4-羟基苯乙烯治疗小鼠Lewis肺癌的研究[J]. 四川大学学报(医学版), 2013, 44(3): 375-378.
引用本文: 郭福春, 王力强, 张静, 等. 二甲双胍联合MCT1抑制剂α-氰基-4-羟基苯乙烯治疗小鼠Lewis肺癌的研究[J]. 四川大学学报(医学版), 2013, 44(3): 375-378.
GUO Fu-chun, WANG Li-qiang, ZHANG Jing, et al. Study on the Anti-Lewis Lung Carcinoma Effect of Metformin Combined with MCT1 Inhibitor CHC[J]. Journal of Sichuan University (Medical Sciences), 2013, 44(3): 375-378.
Citation: GUO Fu-chun, WANG Li-qiang, ZHANG Jing, et al. Study on the Anti-Lewis Lung Carcinoma Effect of Metformin Combined with MCT1 Inhibitor CHC[J]. Journal of Sichuan University (Medical Sciences), 2013, 44(3): 375-378.

栏目: 论著

二甲双胍联合MCT1抑制剂α-氰基-4-羟基苯乙烯治疗小鼠Lewis肺癌的研究

Study on the Anti-Lewis Lung Carcinoma Effect of Metformin Combined with MCT1 Inhibitor CHC

  • 摘要: 目的 探讨二甲双胍联合单羧酸转运蛋白1(monocarboxylate transporter 1,MCT1)抑制剂α氰基-4-羟基苯乙烯(CHC)干扰乳酸代谢是否有抗肿瘤作用。 方法 体外检测对照组、二甲双胍组(1 mmol/L、5 mmol/L)、CHC组(5 mmol/L)及联合用药组(二甲双胍5 mmol/L和CHC 5 mmol/L)24、48 h LL/2细胞的增殖、乳酸代谢的改变及24 h细胞凋亡变化。C57BL/6小鼠于右背侧皮下接种LL/2肿瘤细胞(5×105/只),建立小鼠Lewis肺癌模型,将28只荷瘤小鼠随机平均分为4组:对照组(0.1 mL生理盐水灌胃,同时给予0.1 mL生理盐水腹腔注射)、二甲双胍治疗组(二甲双胍灌胃,200 mg/kg,0.1 mL/只,同时给予0.1 mL生理盐水腹腔注射)、CHC治疗组(CHC腹腔注射,100 mg/kg,0.1 mL/只,同时给予0.1 mL生理盐水灌胃)和联合治疗组(同时给予上述剂量二甲双胍灌胃和CHC腹腔注射)。观察各组小鼠肿瘤生长、测量体积大小并进行肿瘤组织原位凋亡检测。 结果 在体外,联合使用二甲双胍和CHC可以显著增加肿瘤细胞的乳酸生成,同时抑制肿瘤细胞的增殖,与对照组、二甲双胍组和CHC组相比,差异均有统计学意义(P<0.05)。体内动物模型证实联合使用二甲双胍和CHC可以早期减缓肿瘤的生长,与对照组、二甲双胍组和CHC组比较,差异均有统计学意义(P<0.05);同时促进肿瘤细胞的凋亡。 结论 二甲双胍联合CHC可以改变肿瘤细胞乳酸代谢,诱导细胞凋亡,具有一定的抗肿瘤作用。

     

    Abstract: Objecitve To investigate the antitumor effect of the combination of metformin with α-cyano-4-hydroxycinnamic acid (CHC, a MCT1 inhibitor) in the treatment of Lewis lung cancer. Methods In vitro, the utilization of lactate acid was measured by lactate assay in cultured medium and the inhibition of LL/2 cell proliferation of four groups[control group, metformin group (1 mmol/L and 5 mmol/L), CHC group (5 mmol/L) and the combination group (metformin 5 mmol/L and CHC 5 mmol/L)] was detected in 24 h, 48 h, and their apoptosis in 24 h was also detected. In vivo, twenty eight C57BL/6 mice bearing LL/2 (5×105) subcutaneous Lewis lung cancer on the right flank was established and then randomly assigned into four groups:control, metformin (200 mg/kg body mass in 0.1 mL i.g. with NS 0.1 mL i.p.), CHC (100 mg/kg body mass in 0.1 mL i.p. with NS 0.1 mL i.g.) and the combination (metformin 200 mg/kg body mass in 0.1 mL i.g. with CHC 100 mg/kg body mass in 0.1 mL i.p.). Tumor volume was measured. The pathologic observation and apoptotic analysis of tumors was assessed by TUNEL assay. Results Compared to the contorl, metformin or CHC alone, combination of two drugs leaded to a significant lactate acid production in cultured medium and the inhibition of LL/2 cell viability (P<0.05). In vivo, the systemic administration of two drugs leaded to obvious retarded tumor growth compared with used alone in early stage (P<0.05). The TUNEL assay showed the significantly increased number of apoptosis cells in tumor tissues from the combination group. Conclusion Combination of metformin and CHC transformed the lactic acid metabolism in LL/2 cells and induced cell apoptosis and showed the antitumor effect.

     

  • [1]

    Weng XC, Zheng JQ, Jin QE, et al. Inhibition of acid-induced apoptosis by targeting ASIC1a mRNA with short hairpin RNA. Acta Pharmacol Sin,2007;28(10):1621-1627.

    [2]

    Coss RA, Storck CW, Daskalakis C, et al. Intracellular acidification abrogates the heat shock response and compromises survival of human melanoma cells. Mol Cancer Ther,2003;2(4):383-388.

    [3]

    Furlong IJ, Ascaso R, Lopez Rivas A, et al. Intracellular acidification induces apoptosis by stimulating ICE-like protease activity. J Cell Sci,1997;110 (5):653-661.

    [4]

    Sonveaux P, Végran F, Schroeder T, et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest,2008;118(12):3930-3942.

    [5]

    Zhou G, Myers R, Li Y,et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest,2001;108(8):1167-1174.

    [6]

    DeBerardinis RJ, Lum JJ, Hatzivassiliou G, et al. The biology of cancer:metabolic reprogramming fuels cell growth and proliferation. Cell Metab,2008;7(1):11-20.

    [7]

    Ben Sahra I, Laurent K, Giuliano S, et al. Targeting cancer cell metabolism:the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells. Cancer Res,2010;70(6):2465-2475.

    [8]

    Pedersen P. The cancer cell's "power plants" as promising therapeutic targets:an overview. J Bioenerg Biomembr,2007;39(1):1-12.

    [9]

    Rofstad EK, Mathiesen B, Kindem K, et al. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res,2006;66(13):6699-6707.

    [10]

    Gatenby RA, Gawlinski ET, Gmitro AF, et al. Acid-mediated tumor invasion:a multidisciplinary study. Cancer Res,2006;66(10):5216-5223.

    [11]

    Fischer K, Hoffmann P, Voelkl S, et al. Inhibitory effect of tumor cell derived lactic acid on human T cells. Blood,2007;109(9):3812-3819.

    [12]

    Gottfried E, Kunz-Schughart LA, Ebner S, et al. Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood,2006;107(5):2013-2021.

    [13]

    Végran F, Boidot R, Michiels C, et al. Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis. Cancer Res,2011;71(7):2550-2560.

计量
  • 文章访问数: 
  • HTML全文浏览量: 
  • PDF下载量: 
  • 被引次数: 0
出版历程
  • 收稿日期:  2012-10-08
  • 修回日期:  2013-02-21
  • 发布日期:  2013-05-19

目录

    /

    返回文章
    返回